GSK in talks to buy cancer drugmaker Nuvalent for over $9 bln, FT reports
GSK in talks to buy cancer drugmaker Nuvalent for over $9 bln, FT reports
Source link
Similar Posts
Sector : Power Stocks
Source link
BC-OILS
Get stock market news alerts: Sign Up xmlns=”http://iptc.org/std/NITF/2006-10-18/”>NEW YORK (AP) — Futures trading on the New York Mercantile Exchange Friday: Before you make your next trade, you’ll want to hear this. MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis….
Sebi flags surge in social media stock scams. Here’s how to to find registered intermediaries
Capital market regulator, the Securities and Exchange Board of India (Sebi) on Friday warned investors against a sharp rise in market scams perpetrated by fraudsters through social media platforms such as YouTube, Instagram, X (erstwhile Twitter), WhatsApp, Telegram, and app stores. In a press release issued today, Sebi said that scamsters are increasingly using these…
Optimization Phase: Scalping Strategy Performance Feedback (XAUUSD)
Hello fellow traders, I am currently evaluating a specific configuration for my latest scalping strategy, specifically optimized for Gold (XAUUSD). I invite you to test these parameters on a demo account to observe their performance across the M1, M5, and M15 timeframes under current market conditions. Your feedback is essential for further optimization. I am particularly interested in: Execution consistency…
Shakespeare’s Investments
Source: Financial Times Source link
Beam Therapeutics: A Slow-Developing Story (NASDAQ:BEAM)
Beam Therapeutics: A Slow-Developing Story Source link
